Eleven 2,2′-bipyridine (bpy) ligands functionalized
with
attachment groups for covalent immobilization on silicon surfaces
were prepared. Five of the ligands feature silatrane functional groups
for attachment to metal oxide coatings on the silicon surfaces, while
six contain either alkene or alkyne functional groups for attachment
to hydrogen-terminated silicon surfaces. The bpy ligands were coordinated
to Re(CO)5Cl to form complexes of the type Re(bpy)(CO)3Cl, which are related to known catalysts for CO2 reduction. Six of the new complexes were characterized using X-ray
crystallography. As proof of principle, four molecular Re complexes
were immobilized on either a thin layer of TiO2 on silicon
or hydrogen-terminated silicon. The surface-immobilized complexes
were characterized using X-ray photoelectron spectroscopy, IR spectroscopy,
and cyclic voltammetry (CV) in the dark and for one representative
example in the light. The CO stretching frequencies of the attached
complexes were similar to those of the pure molecular complexes, but
the CVs were less analogous. For two of the complexes, comparison
of the electrocatalytic CO2 reduction performance showed
lower CO Faradaic efficiencies for the immobilized complexes than
the same complex in solution under similar conditions. In particular,
a complex containing a silatrane linked to bpy with an amide linker
showed poor catalytic performance and control experiments suggest
that amide linkers in conjugation with a redox-active ligand are not
stable under highly reducing conditions and alkyl linkers are more
stable. A conclusion of this work is that understanding the behavior
of molecular Re catalysts attached to semiconducting silicon is more
complicated than related complexes, which have previously been immobilized
on metallic electrodes.
We report a precious-metal-free molecular catalyst-based photocathode that is active for aqueous CO 2 reduction to CO and methanol. The photoelectrode is composed of cobalt phthalocyanine molecules anchored on graphene oxide which is integrated via a (3aminopropyl)triethoxysilane linker to p-type silicon protected by a thin film of titanium dioxide. The photocathode reduces CO 2 to CO with high selectivity at potentials as mild as 0 V versus the reversible hydrogen electrode (vs RHE). Methanol production is observed at an onset potential of À 0.36 V vs RHE, and reaches a peak turnover frequency of 0.18 s À 1 . To date, this is the only molecular catalyst-based photoelectrode that is active for the six-electron reduction of CO 2 to methanol. This work puts forth a strategy for interfacing molecular catalysts to p-type semiconductors and demonstrates state-of-the-art performance for photoelectrochemical CO 2 reduction to CO and methanol.
We report a precious‐metal‐free molecular catalyst‐based photocathode that is active for aqueous CO2 reduction to CO and methanol. The photoelectrode is composed of cobalt phthalocyanine molecules anchored on graphene oxide which is integrated via a (3‐aminopropyl)triethoxysilane linker to p‐type silicon protected by a thin film of titanium dioxide. The photocathode reduces CO2 to CO with high selectivity at potentials as mild as 0 V versus the reversible hydrogen electrode (vs RHE). Methanol production is observed at an onset potential of −0.36 V vs RHE, and reaches a peak turnover frequency of 0.18 s−1. To date, this is the only molecular catalyst‐based photoelectrode that is active for the six‐electron reduction of CO2 to methanol. This work puts forth a strategy for interfacing molecular catalysts to p‐type semiconductors and demonstrates state‐of‐the‐art performance for photoelectrochemical CO2 reduction to CO and methanol.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.